@fluidx-ad.bsky.social
We are an #H2020 funded research project coordinated by Oslo University Hospital. Our mission is to develop a novel test trio to detect peptide biomarkers in saliva and blood for enhanced diagnosis and management of Alzheimer's disease.
Members of the @fluidx-ad.bsky.social Advisory Board consult about findings from systematic review about the effects of diagnosing Alzheimer's disease via fluid-based biomarker tests.
Thanks for their feedback & the engaged discussion!
www.fluidx-ad.eu/fluidx-ad-co...
@alzheimereurope.bsky.social
Members of the @fluidx-ad.bsky.social projects' Advisory Board held their first online meeting.
FluiDx-AD is a collaborative project aimed at improving Alzheimerโs disease diagnosis & management through the development of innovative saliva and blood-based tests.
www.fluidx-ad.eu/members-of-t...
Yesterday, project partners Faye Forsyth & @chrisbintener.bsky.social met with members of @alzheimereurope.bsky.social European Working Group of People with Dementia to discuss how to implement feedback on a saliva sample collection procedure to screen for #Alzheimerโs disease biomarkers. #EWGPWD
27.11.2025 07:19 โ ๐ 3 ๐ 2 ๐ฌ 0 ๐ 0
Today, Faye Forsyth & I met Praveen Sharma to discuss feedback from EWGPWD and EDCWG on a device to detect Alzheimerโs disease biomarkers in saliva.
Next week weโll focus on how to communicate test results with potential future users: fluidx-ad.eu
Have a read of @alzheimereurope.bsky.social newsletter, featuring the first #H2020 @fluidx-ad.bsky.social General Assembly & a consultation with the European Working Group of People with Dementia & European Dementia Carers Working Group on a saliva prototype for Alzheimerโs disease biomarkers.
03.11.2025 07:32 โ ๐ 1 ๐ 0 ๐ฌ 0 ๐ 0HemoDx, is developing a saliva collection device that could enable cheaper and easier screening for #Alzheimerโs disease.
Together with @alzheimereurope.bsky.social, people affected by dementia provided feedback through structured Public Involvement consultations.
www.fluidx-ad.eu/fluidx-ad-co...
The @fluidx-ad.bsky.social consortium met in Bologna to review progress and plan next steps in developing saliva, plasma and blood tests to improve early diagnosis & management of #Alzheimerโs disease.
Read more: www.fluidx-ad.eu/fluidx-ad-co...
Ahead of @alzheimereurope.bsky.social #35AEC Bologna: members of the European Working Group of People with Dementia & the European Dementia Carers Working Group are consulting on @fluidx-ad.bsky.social prototype saliva-based screening tests for Alzheimerโs disease risk indication.
www.fluidx-ad.eu
Anti-amyloid therapies cause ARIA in a subset of patients. We are working on blood-based biomarkers & a whole-blood ex vivo assay to help identify who may benefit and who may be at higher risk, supporting eligibility assessment & monitoring.
www.fluidx-ad.eu #WorldAlzMonth #WAM2025
Accessible, low-burden testing matters. FluiDx-AD is working towards validation of saliva and plasma biomarkers as well as automated workflows that fit routine clinics, with documentation to support future regulatory steps. www.fluidx-ad.eu
#WorldAlzMonth #WAM2025
โLow-cost & simpleโ matters when you are waiting for answers. Earlier diagnosis helps people plan, seek support, and know what to expect. We aim to evaluate a three-test approach using saliva & blood biomarkers to support earlier, reliable decisions.
#WorldAlzMonth #WAM2025 www.fluidx-ad.eu
Early answers open access to support. FluiDx-AD aims to develop and validate three complementary tests: saliva risk indication, plasma confirmation, and a whole blood ex-vivo assay for ARIA risk to guide therapy decisions. #WorldAlzMonth #WAM2025 #WorldAlzheimersMonth
www.fluidx-ad.eu
Early, reliable answers help families plan.
FluiDx-AD aims to develop & validate three complementary, minimally invasive tests (saliva-based risk indication, plasma-based confirmatory biomarkers, & an assay for ARIA assessment). www.fluidx-ad.eu
#WorldAlzMonth #WAM2025
In FluiDx-AD, we aim to develop & validate a trio of saliva- and blood-based tests to support earlier detection, precise confirmation, and ARIA risk assessment for therapy decisions. More information: www.fluidx-ad.eu
#WorldAlzheimersMonth #WAM2025 #WorldAlzMonth
People may have to wait far too long for an Alzheimerโs disease diagnosis.
FluiDx-AD aims to shorten diagnostic pathways by developing & standardising fluid-based biomarker tests. linktr.ee/FluiDx_AD
#WorldAlzheimersMonth #WAM2025 #WorldAlzMonth
๐ง On #WorldBrainDay #WBD2025 we highlight FluiDx-AD, improving early Alzheimerโs diagnosis with saliva & blood-based tests.
Led by Oslo University Hospital & Pre Diagnostics, with Alzheimer Europe leading on communication & Public Involvement.
๐ฅ vimeo.com/1058971988
๐ linktr.ee/FluiDx_AD
The AI-Mind project builds AI tools to scan brain connectivity and predict dementia risk, giving clinicians earlier insight.
Horizon Europe spin-off @fluidx-ad.bsky.social proves the impact. Details in Alzheimer Europe's Dementia in Europe Magazine supplement
www.alzheimer-europe.org/sites/defaul...
Survey Study Aims to Assess Germanyโs Readiness for Early #Alzheimer Diagnosis Using Biomarkers #ADPD2025
๐ www.neurologylive.com/view/survey-...
A new study shows a saliva test outperforms current blood tests in predicting prostate cancer risk.
@fluidx-ad.bsky.social aims to do the same for #Alzheimerโs, with SalivaDx-AD enabling easy at-home risk detection.
www.alzheimer-europe.org/our-work/cur...
www.theguardian.com/society/2025...
A big thank you to @geriatricarea.bsky.social, who shared our press release about the launch of @fluidx-ad.bsky.social in their news coverage!
Link (in Spanish!) below โฌ
www.geriatricarea.com/2025/04/03/e...
The new Alzheimer Europe Dementia in Europe Magazine features an interview with our Scientific Coordinator Erik Christensen, putting a spotlight on the novel test trio to detect peptide biomarkers for enhanced diagnosis & management of #Alzheimer's disease โคต๏ธ
www.alzheimer-europe.org/sites/defaul...
@fluidx-ad.bsky.social is set to improve #Alzheimerโs disease diagnosis with minimally invasive, cost-effective saliva & blood tests.
Learn more: alzheimereurope.newsweaver.com/ConferenceAn...
www.vimeo.com/1058971988
